Sanofi-Aventis SA has won the agreement of Genzyme Corp’s management to acquire the US company for $74 per share in cash, plus special milestone payments if certain product goals are met. The offer is an increase from $69 per share. ---Subscribe to MedNous to access this article--- Finance, Grants, Deals Company News
